Michael Rosol | Chief Medical Officer |
Erika Eves | Vice President, Finance and Administration |
Edward English | Private Investor |
Greetings. Welcome to the Navidea Biopharmaceuticals Fourth Quarter Earnings Conference Call. [Operator Instructions] And please note that this conference is being recorded. I will now turn the conference over to Michael Rosol, Chief Medical Officer. Thank you.